The pulmonary delivery of insulin may reduce the need for multiple daily subcutaneous injections of insulin for many patients with diabetes. The lungs are an attractive site for delivery of insulin ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

WASHINGTON (AP) - The first inhalable version of insulin won federal approval Friday, giving millions of adult diabetics an alternative to some of the injections they now endure. The Food and Drug ...

Dec. 31, 2003 — Preprandial inhaled insulin via AERx insulin diabetes management system (iDMS) is as effective as preprandial subcutaneous insulin in patients with type 2 diabetes. Results of the ...

This is an exciting time in the treatment of diabetes. Continuous, subcutaneous insulin infusion and continuous glucose monitoring technologies are making optimal glucose control accessible to more ...

CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin as a safe and effective replacement for rapid-acting meal insulin in children with type 1 diabetes. Results from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among adults with type 2 diabetes, ...

Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central Drugs Standard Control ...